Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
Front Neurol 2021 Nov 01;12(xx)716548, JM Serra López-Matencio, Y Pérez García, V Meca-Lallana, R Juárez-Sánchez, A Ursa, L Vega-Piris, D Pascual-Salcedo, A de Vries, T Rispens, C Muñoz-CallejaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.